Answers are grounded in this paper and cite their sources.
Sections of Infectious Diseases and Critical Care Medicine, Wake Forest University School of Medicine, Winston-Salem, NC. *See also p. 1623. Dr. Maves receives research funding for clinical trial support paid to his institution from AiCuris, Geovax, and Sound Pharmaceuticals, as well as direct honoraria for consultative work from Shionogi and LumaBridge, all unrelated to the current article.
No takes yet. Share an insight, caveat, or question.
Ryan C. Maves (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: